408 facial , high risk ( diameter at least 1cm , H-zone location or aggressive histological subtype ) primary BCCs ( pBCCs ) and 204 facial recurrent BCCs ( rBCCs ) were randomly allocated to treatment with either SE or MMS between 5th October 1999 and 27th February 2002 .